Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor’s Perspective

Introduction Evidence-based clinical data on coronavirus disease 2019 (COVID-19) pharmacotherapies are scarce . Objective This study documented and characterized COVID-19 cases reported in individuals receiving treatment with Pfizer pharmaceutical products and cases that reported use of Pfizer pharm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug safety 2021-01, Vol.44 (1), p.95-105
Hauptverfasser:	Beyzarov, Elena, Chen, Yan, Julg, Rob, Naim, Karen, Shah, Jigna, Gregory, William W., Ayoub, Ayman, Caubel, Patrick
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse Drug Reaction Reporting Systems - standards Adverse Drug Reaction Reporting Systems - trends Adverse events Age Antibiotics Anticoagulants Anticoagulants - adverse effects Antimalarial agents Antimalarials - adverse effects Antiretroviral agents Antiviral agents Antiviral Agents - adverse effects Azithromycin Ceftriaxone Chloroquine Coronaviruses Corticoids Corticosteroids COVID-19 COVID-19 - drug therapy COVID-19 - epidemiology Databases, Factual - standards Databases, Factual - trends Diarrhea Dictionaries Drug Industry - standards Drug Industry - trends Drug interaction Drug interactions Drug Safety and Pharmacovigilance Drug therapy Drug-Related Side Effects and Adverse Reactions - diagnosis Drug-Related Side Effects and Adverse Reactions - epidemiology EKG Electrocardiography Global Health - standards Global Health - trends Health services Health surveillance Heart Hepatitis Hospitalization Humans Hydroxychloroquine Immunosuppressive Agents - adverse effects Infections Interferon Lopinavir Medicine Medicine & Public Health Original Original Research Article Patient safety Pharmaceuticals Pharmacology Pharmacology/Toxicology Pharmacovigilance Prolongation Retrospective Studies Ritonavir Safety Severe acute respiratory syndrome coronavirus 2 Torsades de pointes Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!